BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND Cytokeratin�fragment 21-1 AND Staging
51 results:

  • 1. Time between imaging and surgery is not a risk factor for upstaging of clinical stage IA non-small-cell lung cancer.
    Barcelos RR; Sugarbaker E; Kennedy KF; McAllister M; Kim S; Herrera-Zamora J; Leo R; Swanson S; Ugalde Figueroa P
    Eur J Cardiothorac Surg; 2024 Feb; 65(2):. PubMed ID: 38407382
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Relevance of tumor markers for prognosis and predicting therapy response in non-small cell lung cancer patients: A CEPAC-TDM biomarker substudy.
    Geiger K; Joerger M; Roessler M; Hettwer K; Ritter C; Simon K; Uhlig S; Holdenrieder S
    Tumour Biol; 2024; 46(s1):S191-S206. PubMed ID: 38363625
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Correlation Analysis of KCNQ1 Gene Polymorphism with Blood Indexes and Prognosis of Non-Small Cell lung cancer.
    Xie G; Yang Y; Zeng W; Liu Y; Gui B
    Clin Lab; 2024 Feb; 70(2):. PubMed ID: 38345992
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Improved overall survival for Stage III NSCLC patients treated with curative-intended therapy from 2010 to 2018-a cohort study in Denmark.
    Meldgaard P; Kristensen M; Conte S; Kaae Andersen K; Jovanovic A; Meldgaard E
    Acta Oncol; 2023 Dec; 62(12):1672-1679. PubMed ID: 37699061
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Ventilatory Strategy to Prevent Atelectasis During Bronchoscopy Under General Anesthesia: A Multicenter Randomized Controlled Trial (Ventilatory Strategy to Prevent Atelectasis -VESPA- Trial).
    Salahuddin M; Sarkiss M; Sagar AS; Vlahos I; Chang CH; Shah A; Sabath BF; Lin J; Song J; Moon T; Norman PH; Eapen GA; Grosu HB; Ost DE; Jimenez CA; Chintalapani G; Casal RF
    Chest; 2022 Dec; 162(6):1393-1401. PubMed ID: 35803302
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The diagnostic significance of circulating lncRNA ADAMTS9-AS2 tumor biomarker in non-small cell lung cancer among the Egyptian population.
    Abdul-Maksoud RS; Rashad NM; Elsayed WSH; Elsayed RS; Sherif MM; Abbas A; El Shabrawy M
    J Gene Med; 2021 Dec; 23(12):e3381. PubMed ID: 34312940
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Elevated preoperative CEA is associated with subclinical nodal involvement and worse survival in stage I non-small cell lung cancer: a systematic review and meta-analysis.
    Nasralla A; Lee J; Dang J; Turner S
    J Cardiothorac Surg; 2020 Oct; 15(1):318. PubMed ID: 33059696
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Combination of Bronchial Arterial Infusion Chemotherapy plus Drug-Eluting Embolic Transarterial Chemoembolization for Treatment of Advanced lung cancer-A Retrospective Analysis of 23 Patients.
    Zeng Y; Yin M; Zhao Y; Liu Y; Li X; Qi Y; Ma Y; Li Z; Li C; Wu G
    J Vasc Interv Radiol; 2020 Oct; 31(10):1645-1653. PubMed ID: 32951974
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Diagnostic Yield of staging Brain MRI in Patients with Newly Diagnosed Non-Small Cell lung cancer.
    Kim M; Suh CH; Lee SM; Kim HC; Aizer AA; Yanagihara TK; Bai HX; Guenette JP; Huang RY; Kim HS
    Radiology; 2020 Nov; 297(2):419-427. PubMed ID: 32840470
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Analysis of efficacy and prognosis of Osimertinib combined with docetaxel for non-small cell lung cancer.
    Huang Y; Shi Y; Yin X; Zhang Q
    J BUON; 2020; 25(2):805-810. PubMed ID: 32521871
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Addition of chemotherapy improves overall survival in patients with T2N0M0 non-small cell lung cancer undergoing definitive radiation therapy: An analysis of the SEER database.
    Komiya T; Chaaya G; Powell E
    Radiother Oncol; 2019 Feb; 131():75-80. PubMed ID: 30773190
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinical characteristics and prognostic analysis of multiple primary malignant neoplasms in patients with lung cancer.
    Wang H; Hou J; Zhang G; Zhang M; Li P; Yan X; Ma Z
    Cancer Gene Ther; 2019 Nov; 26(11-12):419-426. PubMed ID: 30700800
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Association of Chemoradiotherapy With Outcomes Among Patients With Stage I to II vs Stage III Small Cell lung cancer: Secondary Analysis of a Randomized Clinical Trial.
    Salem A; Mistry H; Hatton M; Locke I; Monnet I; Blackhall F; Faivre-Finn C
    JAMA Oncol; 2019 Mar; 5(3):e185335. PubMed ID: 30520977
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Effect of adipose tissue volume on prognosis in patients with non-small cell lung cancer.
    Lee JW; Lee HS; Na JO; Lee SM
    Clin Imaging; 2018; 50():308-313. PubMed ID: 29751203
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. High preoperative and postoperative levels of carcinoembryonic antigen and CYFRA 21-1 indicate poor prognosis in patients with pathological Stage I nonsmall cell lung cancer.
    Duan X; Cui Y; Li H; Shi G; Wu B; Liu M; Chang D; Wang T; Kong Y
    Indian J Cancer; 2015 Dec; 52 Suppl 3():E158-63. PubMed ID: 27453414
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancer.
    Cho A; Hur J; Moon YW; Hong SR; Suh YJ; Kim YJ; Im DJ; Hong YJ; Lee HJ; Kim YJ; Shim HS; Lee JS; Kim JH; Choi BW
    BMC Cancer; 2016 Mar; 16():224. PubMed ID: 26979333
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Relationship between pretreatment levels of serum Cyfra 21.1, CEA and PET metabolic parameters in NSCLC.
    Dogan I; Karyagar S; Karyagar SS; Kahraman C; Alver A
    Ann Nucl Med; 2014 Nov; 28(9):829-35. PubMed ID: 24990528
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Toward rapid, high-sensitivity, volume-constrained biomarker quantification and validation using backscattering interferometry.
    Olmsted IR; Hassanein M; Kussrow A; Hoeksema M; Li M; Massion PP; Bornhop DJ
    Anal Chem; 2014 Aug; 86(15):7566-74. PubMed ID: 24954171
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Predictive factors for node metastasis in patients with clinical stage I non-small cell lung cancer.
    Cho S; Song IH; Yang HC; Kim K; Jheon S
    Ann Thorac Surg; 2013 Jul; 96(1):239-45. PubMed ID: 23673071
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Video-assisted vs open mediastinal lymphadenectomy for Stage I non-small-cell lung cancer: results of a prospective randomized trial.
    Palade E; Passlick B; Osei-Agyemang T; Günter J; Wiesemann S
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):244-9; discussion 249. PubMed ID: 23295451
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.